Boardroom Alpha
Meeting calendar
CC · Annual meeting · Friday, April 24, 2026

Chemours Co

11 nominees · 4 ballot items.

Election of eleven directors; advisory (non-binding) vote to approve named executive officer compensation; approval of the Chemours Company 2026 Equity and Incentive Plan; ratification of PricewaterhouseCoopers LLP as independent auditors.

Market cap
$2.6B
1Y TSR
+49.2%
Board grade
C
Record date
Mar 2, 2026
Filing
DEF 14A
Meeting concluded · Apr 24, 2026

Follow how the vote landed and what changed on Chemours Co’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot4

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect eleven director nominees named in the proxy statement to serve one-year terms until the 2027 annual meeting.

  2. 2

    Advisory Vote on Executive Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding advisory vote to approve the compensation of the company’s named executive officers as disclosed in the proxy statement.

  3. 3

    Approval of The Chemours Company 2026 Equity and Incentive Plan

    ManagementBoard: FOR

    Approve the 2026 Equity and Incentive Plan to reserve 6,375,275 shares for awards and allow continued equity compensation to employees, directors and consultants.

  4. 4

    Ratification of Selection of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify the Audit Committee’s selection of PricewaterhouseCoopers LLP as the company’s independent registered public accounting firm for fiscal year 2026.

Director elections

Nominees on the ballot11

Independent
Tenure on this board
1.2 yrs
Also a director at
Alico Inc (ALCO)Cto Realty Growth Inc (CTO)Echostar Corp (ECHO)
Independent
Tenure on this board
11.5 yrs
Also a director at
Tpg Inc (TPG)
Not independent
Tenure on this board
2.3 yrs
Also a director at
Kulicke & Soffa Industries Inc (KLIC)
Independent
Tenure on this board
2.4 yrs
Also a director at
Lumentum Holdings Inc (LITE)
Independent
Tenure on this board
7.1 yrs
Also a director at
Advansix Inc (ASIX)
Independent
Tenure on this board
8.2 yrs
Also a director at
Cabot Corp (CBT)
Independent
Tenure on this board
1.4 yrs
Also a director at
Firstenergy Corp (FE)
Ownership

Top institutional holders10

Latest 13F quarter
1BlackRock, Inc.10.5%15,813,238$348M
2VANGUARD PORTFOLIO MANAGEMENT LLC6.9%10,325,341$227M
3VANGUARD CAPITAL MANAGEMENT LLC4.5%6,773,917$149M
4STATE STREET CORP4.1%6,123,088$135M
5AMERIPRISE FINANCIAL INC3.2%4,739,228$104M
6BlackRock, Inc.2.9%4,420,710$97M
7AMERICAN CENTURY COMPANIES INC2.9%4,415,864$97M
8Wolf Hill Capital Management, LP2.5%3,689,794$81M
9GEODE CAPITAL MANAGEMENT, LLC2.0%3,074,437$68M
10JPMORGAN CHASE CO2.0%3,055,950$65M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Chemours Co 2026 annual meeting?
Chemours Co (CC) holds its 2026 annual shareholder meeting on Friday, April 24, 2026.
What is the record date for the Chemours Co 2026 meeting?
The record date for the Chemours Co 2026 meeting is Monday, March 2, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Chemours Co's 2026 meeting?
The board is presenting 11 director nominees at the Chemours Co 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Chemours Co 2026 meeting?
Shareholders will vote on 4 proposals at the Chemours Co 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer